Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
- 1 August 2012
- journal article
- review article
- Published by Elsevier BV in Cell Metabolism
- Vol. 16 (2), 153-166
- https://doi.org/10.1016/j.cmet.2012.06.011
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- P‐selectin genotype is associated with the development of cancer cachexiaEMBO Molecular Medicine, 2012
- FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and SignalingCell Metabolism, 2012
- C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wastingThe EMBO Journal, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Intramyocellular lipid droplets increase with progression of cachexia in cancer patientsJournal of Cachexia, Sarcopenia and Muscle, 2011
- Hypothalamic mechanisms in cachexiaPhysiology & Behavior, 2010
- Lipid-induced insulin resistance: unravelling the mechanismThe Lancet, 2010
- The initiation factor eIF3-f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophyThe EMBO Journal, 2008
- Fast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese MiceCell Metabolism, 2008
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002